Gallium-68 dotatate (DrugBank: Dotatate)
3 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
41 | 巨細胞性動脈炎 | 0 |
75 | クッシング病 | 0 |
84 | サルコイドーシス | 2 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03746847 (ClinicalTrials.gov) | December 1, 2018 | 29/10/2018 | PET Imaging in Patients With Suspected Cardiac Sarcoidosis | Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis | Cardiac Sarcoidosis | Drug: Gallium-68 DOTATATE | University of Pennsylvania | Advanced Accelerator Applications | Recruiting | 18 Years | N/A | All | 20 | United States | |
2 | NCT02546388 (ClinicalTrials.gov) | October 2015 | 9/9/2015 | Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis | Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis | Sarcoidosis | Drug: Indium-111 Pentreotide;Drug: Gallium-68 DOTATATE | Marcelo F. Di Carli, MD, FACC | Mallinckrodt | Completed | 18 Years | 90 Years | All | 17 | N/A | United States |